RxDoctor Payments Data

Cody Whittington, NP

Family · Summersville, MONPI 1326684945

Payments from drug & device makers

$1,920in general payments, 2019–2025

Across 26 payments — averaging $73.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$679
  • Medtronic$486
  • Endologix LLC$211
  • Kestra Medical Technology Services, Inc.$177
  • Heartflow, Inc.$150
  • Biosense Webster, Inc.$122
  • plus $95 from 5 others

What the payments were for

  • Travel & lodging$18810%
  • Food & beverage$1,73290%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,920 in reported general payments places this provider in the 80th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$43,226
Medicare patients
444
Services billed
619

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban334$266,812
XareltoRivaroxaban73$55,391
EntrestoSacubitril/Valsartan49$40,552
Flecainide Acetate171$6,320
Metoprolol Succinate417$4,255
Dofetilide36$2,896
Amiodarone Hcl66$1,662
Diltiazem 24hr Er (Cd)Diltiazem Hcl101$1,504
Losartan Potassium73$571
Potassium Chloride28$368
Torsemide48$299
SotalolSotalol Hcl22$295
Carvedilol70$162
Amlodipine Besylate52$160
Furosemide39$88

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$18$266,812334 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,812 family providers in Missouri.

Other family in Summersville

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →